These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 17701678)

  • 1. Circadian variations in coagulation and fibrinolytic factors among four different strains of mice.
    Ohkura N; Oishi K; Sakata T; Kadota K; Kasamatsu M; Fukushima N; Kurata A; Tamai Y; Shirai H; Atsumi G; Ishida N; Matsuda J; Horie S
    Chronobiol Int; 2007; 24(4):651-69. PubMed ID: 17701678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of Clock in circulatory system leads to an enhancement of fibrinolysis in mice.
    Cheng S; Jiang Z; Zou Y; Chen C; Wang Y; Liu Y; Xiao J; Guo H; Wang Z
    Exp Biol Med (Maywood); 2011 Sep; 236(9):1078-84. PubMed ID: 21750017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circadian clock molecules CLOCK and CRYs modulate fibrinolytic activity by regulating the PAI-1 gene expression.
    Ohkura N; Oishi K; Fukushima N; Kasamatsu M; Atsumi GI; Ishida N; Horie S; Matsuda J
    J Thromb Haemost; 2006 Nov; 4(11):2478-85. PubMed ID: 16970803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketogenic diet disrupts the circadian clock and increases hypofibrinolytic risk by inducing expression of plasminogen activator inhibitor-1.
    Oishi K; Uchida D; Ohkura N; Doi R; Ishida N; Kadota K; Horie S
    Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1571-7. PubMed ID: 19628783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circadian mRNA expression of coagulation and fibrinolytic factors is organ-dependently disrupted in aged mice.
    Oishi K; Koyanagi S; Ohkura N
    Exp Gerontol; 2011 Dec; 46(12):994-9. PubMed ID: 21963655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proxisome proliferator-activated receptor-α mediates high-fat, diet-enhanced daily oscillation of plasminogen activator inhibitor-1 activity in mice.
    Hayashida S; Kuramoto Y; Koyanagi S; Oishi K; Fujiki J; Matsunaga N; Ikeda E; Ohdo S; Shimeno H; Soeda S
    Chronobiol Int; 2010 Oct; 27(9-10):1735-53. PubMed ID: 20969520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of circadian clock gene Clock in diabetes-induced circadian augmentation of plasminogen activator inhibitor-1 (PAI-1) expression in the mouse heart.
    Oishi K; Ohkura N; Amagai N; Ishida N
    FEBS Lett; 2005 Jul; 579(17):3555-9. PubMed ID: 15950223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue-specific augmentation of circadian PAI-1 expression in mice with streptozotocin-induced diabetes.
    Oishi K; Ohkura N; Kasamatsu M; Fukushima N; Shirai H; Matsuda J; Horie S; Ishida N
    Thromb Res; 2004; 114(2):129-35. PubMed ID: 15306155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PERIOD2 is a circadian negative regulator of PAI-1 gene expression in mice.
    Oishi K; Miyazaki K; Uchida D; Ohkura N; Wakabayashi M; Doi R; Matsuda J; Ishida N
    J Mol Cell Cardiol; 2009 Apr; 46(4):545-52. PubMed ID: 19168071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative hemostatic parameters in BALB/c, C57BL/6 and C3H/He mice.
    Barrios M; Rodríguez-Acosta A; Gil A; Salazar AM; Taylor P; Sánchez EE; Arocha-Piñango CL; Guerrero B
    Thromb Res; 2009 Jul; 124(3):338-43. PubMed ID: 19101712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemostatic/fibrinolytic protein changes in C3H/HeN mice infected with Rickettsia conorii--a model for Rocky Mountain spotted fever.
    Schmaier AH; Srikanth S; Elghetany MT; Normolle D; Gokhale S; Feng HM; Walker DH
    Thromb Haemost; 2001 Sep; 86(3):871-9. PubMed ID: 11583321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects on coagulation and fibrinolysis induced by influenza in mice with a reduced capacity to generate activated protein C and a deficiency in plasminogen activator inhibitor type 1.
    Keller TT; van der Sluijs KF; de Kruif MD; Gerdes VE; Meijers JC; Florquin S; van der Poll T; van Gorp EC; Brandjes DP; Büller HR; Levi M
    Circ Res; 2006 Nov; 99(11):1261-9. PubMed ID: 17068293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneal lavage with activated protein C alters compartmentalized coagulation and fibrinolysis and improves survival in polymicrobial peritonitis.
    van Veen SQ; Levi M; van Vliet AK; Florquin S; van Gulik TM; Boermeester MA
    Crit Care Med; 2006 Nov; 34(11):2799-805. PubMed ID: 17006359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of human coagulation and fibrinolysis assays in domestic pigs.
    Münster AM; Olsen AK; Bladbjerg EM
    Comp Med; 2002 Feb; 52(1):39-43. PubMed ID: 11900411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of isoflavones on the coagulation and fibrinolytic system of postmenopausal women.
    Rios DR; Rodrigues ET; Cardoso AP; Montes MB; Franceschini SA; Toloi MR
    Nutrition; 2008 Feb; 24(2):120-6. PubMed ID: 18065202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of angiotensin and the clock system in the circadian regulation of plasminogen activator inhibitor-1.
    Masuda Y; Emoto N; Nonaka H; Yagita K; Todo T; Okamura H; Yokoyama M; Hirata K
    Kobe J Med Sci; 2009 Mar; 54(6):E264-71. PubMed ID: 19628967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
    Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
    Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circadian variations in natural coagulation inhibitors protein C, protein S and antithrombin in healthy men: a possible association with interleukin-6.
    Undar L; Ertuğrul C; Altunbaş H; Akça S
    Thromb Haemost; 1999 Apr; 81(4):571-5. PubMed ID: 10235441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal stability of coagulation, fibrinolysis, and inflammation factors in stored plasma samples.
    Lewis MR; Callas PW; Jenny NS; Tracy RP
    Thromb Haemost; 2001 Dec; 86(6):1495-500. PubMed ID: 11776319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.